In the recent march newsletter avx is again reminding us that...

  1. 1,901 Posts.
    lightbulb Created with Sketch. 2
    In the recent march newsletter avx is again reminding us that when the $79.9mil was raised, this was enough to complete phase3. Because of the FDA's requirement of a larger trial it looks like it won't be enough. So I hope we get a takeover or partner, otherwise another capital raising is on the way, which is probably holding down the SP as well as the traders.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.